In the sphere of immuno-oncology research, a powerful tool has emerged - the Diet-Induced Obesity (DIO) mouse model. These models provide researchers a practical route to understanding the connections between obesity, immunity, and cancer treatment. The real value of DIO mice lies in their ability to reflect human-like responses, marking a new phase of discovery. Below are the top 5 reasons researchers should be incorporating DIO mice into the preclinical evaluation of immuno-oncology treatments.
August 22, 2023
- The Rising Impact of ADCs in Cancer Treatment
- A Brief History of Flow Cytometry
- Silent but Deadly, and Beneficial? – Natural Killer Cells
- The Basophil Activation Test: An Application of Flow Cytometry for Allergy Testing in Clinical Trials
- Navigating the Preclinical-to-Clinical Transition for ADCs: Regulatory & Study Design Strategies
The Rising Impact of ADCs in Cancer Treatment
Antibody-Drug Conjugates (ADCs) are transforming cancer treatment by harnessing the precision of antibodies combined with highly potent cytotoxic ...
A Brief History of Flow Cytometry
By Darcey L. Clark, MS DABT, Senior Biotechnology Professional
Silent but Deadly, and Beneficial? – Natural Killer Cells
By Jayne Schaubhut, Lab Supervisor Natural Killer (NK) cells play a major role in targeting and killing both tumor cells and virally infected cells ...
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
